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Background: Cardiac structure and function are well-studied in Western countries. However, epidemiological data
is still scarce in China.
Methods: Our study was conducted in the framework of cardiovascular health examinations for the current and
retired employees of a factory and their family members. According to the American Society of Echocardiography
recommendations, we performed echocardiography to evaluate cardiac structure and function, including left atrial
volume, left ventricular hypertrophy and diastolic dysfunction.
Results: The 843 participants (43.0 years) included 288 (34.2%) women, and 191 (22.7%) hypertensive patients, of
whom 82 (42.9%) took antihypertensive drugs. The prevalence of left atrial enlargement, left ventricular hypertrophy
and concentric remodeling was 2.4%, 5.0% and 12.7%, respectively. The prevalence of mild and moderate-to-severe
left ventricular diastolic dysfunction was 14.2% and 3.3%, respectively. The prevalence of these cardiac abnormalities
significantly (P≤ 0.002) increased with age, except for the moderate-to-severe left ventricular diastolic dysfunction.
After adjustment for age, gender, body height and body weight, left atrial enlargement was associated with plasma
glucose (P= 0.009), and left ventricular hypertrophy and diastolic dysfunction were significantly associated with
systolic and diastolic blood pressure (P≤ 0.03), respectively.
Conclusions: The prevalence of cardiac structural and functional abnormalities increased with age in this Chinese
population. Current drinking and plasma glucose had an impact on left atrial enlargement, whereas systolic and
diastolic blood pressures were major correlates for left ventricular hypertrophy and diastolic dysfunction,
respectively.
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pressureBackground
Cardiac structure and function are well-studied in West-
ern populations, such as the Framingham Heart Study
[1,2], the Rotterdam Study [3], and the Atherosclerotic
Risk in Communities (ARIC) Study [4]. Cardiac struc-
tural and functional abnormalities, even if at asymptom-
atic stage, may predict cardiovascular events and
mortality [1-8]. In the Framingham Heart Study, the
echocardiographically diagnosed left ventricular hyper-
trophy was associated with a 73% and 112% higher risk* Correspondence: jiguangw@gmail.com
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reproduction in any medium, provided the orof cardiovascular mortality, and a 49% and 101% higher
risk of all-cause mortality in men and women, respect-
ively [1].
Several clinical studies reported prevalence and cor-
relates of left ventricular hypertrophy in Chinese
hypertensive patients [9,10]. However, there is limited
epidemiological data on cardiac structural and func-
tional abnormalities in Chinese population. We there-
fore performed echocardiographic measurements in the
framework of cardiovascular health examinations for
employees of a factory located in southeast China. In the
present cross-sectional analyses, we investigated the
prevalence and correlates of cardiac structural and func-
tional abnormalities, including left atrial enlargement,
left ventricular hypertrophy and diastolic dysfunction.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Study participants
The present study was conducted in the year 2006 in the
framework of comprehensive cardiovascular health
examinations for all employees (including those retired
but still lived in the area of the factory at the time of the
study) of a factory located in an isolated coast area, 300
kilometers south of Shanghai [11]. The family members
of these employees at least 12 years of age living in the
nearby region were also invited for participation. The
Ethics Committee of Ruijin Hospital, Shanghai Jiaotong
University School of Medicine approved the study proto-
col. All subjects gave written informed consent.
Of the 1052 study subjects (participation rate 80.7%),
877 participated in the echocardiographic study. We
excluded 34 subjects from the present analysis, because
they had poor quality of echocardiogram (n = 9), moder-
ate or severe valvular regurgitation or stenosis (n = 20),
congenital heart disease (n = 3), atrial fibrillation (n = 1)
or hypertrophic cardiomyopathy (n = 1). Thus, the num-
ber of participants included in the present analysis was
843.
Field work
One experienced physician measured each participant’s
blood pressure five times consecutively by conventional
sphygmomanometry, after at least 5 minutes rest in the
sitting position. These five blood pressure readings were
averaged for analyses. The same observer also adminis-
tered a standardized questionnaire to collect information
on medical history, smoking habits, alcohol consump-
tion and the use of medications. Current smoking and
drinking were defined as at least smoking one cigarette
per day or drinking once per week in the past year, re-
spectively. Daily alcohol consumption was calculated
according to the consumption of various types of alco-
holic beverages during the past month. In the study area,
beer was sold in a bottle of 750 mL, whereas yellow
aperitif, rice aperitif and hard liquor were traded in a
unit of 500 grams. We estimated that one bottle of beer
and a unit of aperitif and liquor contained on average
30, 90 and 200 g of ethanol, respectively. From the type
and quantity of the alcoholic beverages used, we com-
puted daily alcohol consumption in grams per day.
Drinking subjects were further categorized into tertiles
of daily alcohol consumption, with mild, moderate and
heavy drinking defined as daily alcohol consumption
<18 g/d, 18 to 36 g/d, and > 36 g/d, respectively. Hyper-
tension was defined as a blood pressure of at least
140 mmHg systolic or 90 mmHg diastolic, or the use of
antihypertensive drugs. One trained technician measured
body height and body weight. Body mass index was cal-
culated as body weight in kg divided by the square of
body height in meters. Venous blood samples were takenafter overnight fasting for measurements of plasma glu-
cose concentration and concentrations of total, high-
density lipoprotein (HDL), and low-density lipoprotein
(LDL) cholesterol and triglycerides.
Echocardiographic measurements
One echocardiographer performed all echocardiographic
measurements using the portable Mylab 30 CV machine
(ESAOTE SpA, Genoa, Italy) according to the American
Society of Echocardiography (ASE) recommendations.
Two-dimensional and color Doppler images were first
recorded, and then analyzed offline. Moderate or severe
valvular regurgitation or stenosis was diagnosed as
valvular heart disease using color Doppler imaging [12].
Left atrial volume was calculated using the ellipse
model formula: left atrial volume = π× (SA1 × SA2×
LA)/6, where SA1 is the M-mode left atrial dimension
in the parasternal short-axis view and SA2 and LA are
measurements of short- and long-axes in the apical four
chamber view at ventricular end-systole [13]. Left atrial
volume was standardized to body size, as left atrial vol-
ume index. Left atrial enlargement was defined as left
atrial volume index ≥ 29 mL/m2 according to ASE
recommendations [14].
Measurements for M-mode guided calculation of left
ventricular mass (LVM) were taken in the parasternal
short-axis view. Left ventricular internal dimension at
end-diastole (LVIDd) and septal (SWTd) and posterior
wall thickness at end-diastole (PWTd) were measured.
LVM was calculated by the ASE recommended formula
[15]: LVM (g) = 0.8 × {1.04 × [(LVIDd + PWTd + SWTd)3 -
(LVIDd)3]} + 0.6, and standardized to body size by dividing
the raw LVM by body surface area, as left ventricular mass
index (LVMI). Relative wall thickness (RWT) was calcu-
lated by the formula: (2×PWTd)/LVIDd, and also used as
a measure of left ventricular geometry [14]. Left ventricular
concentric remodeling and eccentric and concentric hyper-
trophy were defined as RWT>0.42 and LVMI≤115 g/m2
(men) or LVMI ≤ 95 g/m2 (women), RWT> 0.42 and
LVMI > 115 g/m2 (men) or LVMI > 95 g/m2 (women),
and RWT< 0.42 and LVMI > 115 g/m2 (men) or
LVMI > 95 g/m2 (women), respectively [15].
Mitral and pulmonary venous inflow (pulse-wave Dop-
pler) and left atrial volume index were measured for the
diagnosis of left ventricular diastolic dysfunction. Nor-
mal, indeterminate, and mild, moderate and severe left
ventricular diastolic dysfunction were further classified
according to the ASE recommendations [16]. On the
basis of the ratio of early transmitral diastolic peak flow
(E) and atrial peak flow (A, E/A ratio), and the deceler-
ation time of early transmitral diastolic flow (DTE), all
subjects were categorized into 3 groups: category 1 with
an E/A ratio <0.75 and a prolonged DTE (>220 ms),
category 2 with normal range of E/A ratio (0.75 to 1.5)






Age, years 43.5 ± 14.7 42.1 ± 12.5 0.15
Body height, cm 168± 6 158 ± 5 <0.001
Body weight, kg 67.4 ± 9.9 55.8 ± 8.0 <0.001
Body mass index, kg/m2 23.9 ± 3.1 22.5 ± 3.1 <0.001
Body surface area, m2 1.80 ± 0.15 1.58 ± 0.11 <0.001
Systolic blood pressure, mmHg 124.5 ± 18.3 117.5 ± 20.6 <0.001
Diastolic blood pressure, mmHg 76.6 ± 11.4 72.0 ± 10.6 <0.001
Current smoking, % 255 (46.8) 2 (0.7) <0.001
Current drinking, % 209 (38.4) 5 (1.8) <0.001
Taking antihypertensive
drugs, n (%)
61 (11.2) 21 (7.4) 0.08
Plasma glucose, mmol/L 4.37 ± 1.49 4.37 ± 0.75 0.98
Total cholesterol, mmol/L 4.85 ± 0.92 4.76 ± 0.92 0.17
Low-density lipoprotein
cholesterol, mmol/L
3.12 ± 0.83 2.95 ± 0.83 0.005
High-density lipoprotein
cholesterol, mmol/L
1.30 ± 0.35 1.50 ± 0.37 <0.001
Triglycerides, mmol/L 2.17 ± 1.98 1.57 ± 1.10 <0.001
Left atrial volume index, mL/m2 19.3 ± 4.6 18.6 ± 3.8 0.03
Left ventricular mass index, g/m2 85.9 ± 16.2 73.3 ± 14.3 <0.001
Relative wall thickness 0.38 ± 0.05 0.35 ± 0.05 <0.001
Left ventricular ejection fraction, % 62.5 ± 4.9 64.0 ± 5.0 <0.001
E/A ratio 1.15 ± 0.38 1.25 ± 0.39 <0.001
Deceleration time, ms 196 ± 28 183 ± 27 <0.001
Left atrial enlargement, n (%) 15 (2.9) 3 (1.2) 0.14
Left ventricular hypertrophy, n (%) 25 (4.5) 17 (5.9) 0.38
Left ventricular diastolic
dysfunction, n (%)
95 (20.4) 26 (11.4) 0.003
Data are mean ± standard deviation or number with percentage in
parenthesis. E/A ratio indicates the ratio of early transmitral diastolic peak flow
(E) and atrial peak flow (A). Deceleration time indicates the deceleration time
of early transmitral diastolic flow (E). For the definition of left atrial
enlargement, left ventricular hypertrophy and diastolic dysfunction, see
Methods.
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and DTE < 150 ms. Category 1 was diagnosed as mild
left ventricular diastolic dysfunction. Category 2 was fur-
ther differentiated as normal, indeterminate or moderate
left ventricular diastolic dysfunction, if none, only one or
at least 2 of the following 4 abnormalities were respect-
ively present: pulmonary venous systolic velocity less
than diastolic velocity (S/D < 1); pulmonary venous atrial
reversal duration greater than mitral A duration more
than 30 ms (ARD-AD>30 ms); peak of pulmonary ven-
ous atrial reversal wave more than 35 cm/s (AV>35 m/s);
and left atrial volume index more than 29 ml/m2.
Category 3 was further differentiated as indeterminate
or severe left ventricular diastolic dysfunction in the ab-
sence or presence of at least 1 of the 4 above-mentioned
abnormalities. Only in the presence of all echocardio-
graphic measurements mentioned above, left ventricular
diastolic function could be evaluated, so that 150 sub-
jects were excluded, leaving 693 subjects in the analysis
of diastolic dysfunction.
Left ventricular ejection fraction (EF) was measured by
quantitative two-dimensional method (biplane Simpson
method) [14].
Statistical methods
Statistical analysis was performed using SAS software,
version 9.1 (SAS Institute, Cary, USA). Means and pro-
portions were compared by the student’s t-test and Fish-
er’s exact test, respectively. In stepwise linear regression,
we forced age, gender, body weight and body height, and
considered systolic and diastolic blood pressure, current
smoking and drinking, the use of antihypertensive drugs,
plasma glucose, and the total-to-HDL cholesterol ratio
as potential confounders of left atrial volume, LVM and
E/A ratio. We performed stepwise logistic regression
analyses to investigate correlates of left atrial enlarge-
ment, left ventricular hypertrophy and diastolic dysfunc-
tion in the consideration of above-mentioned variables.
In the stepwise regression analysis, P < 0.10 were set as
criteria for independent variables to enter and stay in
the model. We also applied ANOVA to compare the
prevalence of cardiac structural and functional abnor-
malities according to alcohol consumption, plasma glu-
cose, and systolic and diastolic blood pressure.
Results
The 843 participants included 288 (34.2%) women, 191
(22.7%) hypertensive patients (of whom 82 [42.9%] took
antihypertensive drugs), 87 (10.4%) patients with hyper-
lipidemia, 17 (2.0%) patients with diabetes mellitus, and
2 (0.3%) patients with a LVEF less than 50%. Table 1
shows the characteristics of our study subjects. Men and
women had similar age (43.0±14.0 years, range 15 to
79 years), plasma glucose (4.37±1.19 mmol/L) and totalcholesterol (4.82±0.92 mmol/L). However, men, com-
pared with women, had a greater body mass index
(23.9 ± 3.1 vs 22.5 ± 3.1 kg/m2, P < 0.001), higher sys-
tolic/diastolic blood pressure (124.5 ± 18.3/76.7 ± 11.4
vs 117.5 ± 20.6/72.0 ± 10.6 mmHg, P < 0.001), more fre-
quently reported smoking and drinking (46.8% vs
0.7%, 38.4% vs 1.8%, P < 0.001), and had lower HDL
cholesterol (1.30±0.35 vs 1.50±0.37 mmol/L, P<0.001) and
higher LDL cholesterol (3.12±0.83 vs 2.95±0.83 mmol/L,
P=0.005) and triglycerides (2.17±1.98 vs 1.57±1.10 mmol/L,
P< 0.001). All echocardiographic measurements were sig-
nificantly higher in men than women (P≤ 0.03), but
women, compared to men, had significantly higher LVEF
and E/A ratio (P=0.001).
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der, body height and body weight, left atrial volume was
significantly associated with systolic blood pressure
(P < 0.001) and plasma glucose (P= 0.008), LVM with
systolic blood pressure (P < 0.001), and E/A ratio with
diastolic blood pressure (P < 0.001) and the total-to-HDL
cholesterol ratio (P= 0.003, Table 2).
In 843 participants, the prevalence of left atrial en-
largement, and left ventricular concentric remodeling
and hypertrophy was 2.4%, 12.7% and 5.0%, respectively.
In 693 subjects with sufficient echocardiographic mea-
surements to evaluate left ventricular diastolic function,
the prevalence of left ventricular diastolic dysfunction
was 17.5%, with mild and moderate-to-severe stages of
14.2% and 3.3%, respectively. The prevalence of these
cardiac structural and functional abnormalities signifi-
cantly increased with age, except moderate-to-severe left
ventricular diastolic dysfunction (P= 0.08). Indeed, the
prevalence of left ventricular concentric remodeling
increased from 8.3% in subjects younger than 40 years
(n = 421) to 20.9% in subjects of at least 60 years
(n = 134). The corresponding values were from 1.9% to
13.4% for left ventricular hypertrophy, and from 1.5% to
46.6% for left ventricular diastolic dysfunction (Figure 1).
In addition to age, male gender, body height and body
weight, left atrial enlargement was significantly asso-
ciated with plasma glucose (odds ratio [OR] = 1.29, 95%
confidential interval [CI]: 1.06-1.55), left ventricular
hypertrophy with systolic blood pressure (OR= 1.21,
95% CI: 1.02-1.44), and left ventricular diastolic dysfunc-
tion with diastolic blood pressure (OR= 1.29, 95% CI:
1.03-1.62, Table 3). In addition, the prevalence of left
atrial enlargement tended to be higher in drinkers than
non-drinkers (OR= 3.16, 95% CI: 0.88-11.33, P= 0.08).
In further analyses, we studied left atrial enlargement
in men (too small numbers in women) and left ventricu-
lar hypertrophy and diastolic dysfunction in men and
women, separately, in relation to their correlatesTable 2 Cardiac structure and function in relation to convent
Left atrial volume, ml
β ± SE Partial R2 p
Age, (+10 years) 0.79 ± 0.22 0.10 <0.001
Gender, (1 =man, 0 =woman) 0.24 ± 0.71 0.07 0.73
Body height, (+10 cm) -1.10 ± 0.51 0.03 0.03
Body weight, kg 0.49 ± 0.03 0.22 <0.001
Systolic blood pressure, (+10 mmHg) 0.59 ± 0.17 0.01 <0.001
Plasma glucose, mmol/L 0.51 ± 0.19 0.01 0.008
Diastolic blood pressure, (+10 mmHg) – – –
Total-to-HDL cholesterol ratio – – –
In stepwise linear regression, we forced age, gender, body weight and body height
smoking and drinking, the use of antihypertensive drugs, plasma glucose, and total
enter or stay in the model was set at <0.10. β, estimated parameter; SE, standard eridentified from above-mentioned analysis as categorical
variables. The prevalence of left atrial enlargement in
men increased from 1.29% in non-drinkers (n = 309), to
2.25% in mild drinkers (n = 89), to 5.56% in moderate
drinkers (n = 54), and to 10.2% in heavy drinkers (n = 49,
P= 0.003 for trend), and remained at low level (1.3%) in
subjects with a plasma glucose concentration below
4.70 mmol/L (quartiles 1 to 3) and increased to 7.3% in
subjects with plasma glucose concentration above
4.70 mmol/L (quartile 4, Figure 2). The prevalence of
left ventricular hypertrophy and diastolic dysfunction
increased with higher levels of systolic and diastolic
blood pressure, respectively, but with slightly steeper
slope in women for hypertrophy (P for interaction =
0.89) and in men for diastolic dysfunction (P for inter-
action= 0.30, Figure 3).
Discussion
To our knowledge, our study is the first that has
reported the prevalence and correlates of the echocar-
diographically diagnosed left atrial enlargement, left ven-
tricular hypertrophy and diastolic dysfunction in an
epidemiological setting in a Chinese population. In our
study, the prevalence of left atrial enlargement, left ven-
tricular hypertrophy and diastolic dysfunction was 2.4%,
5.0% and 17.5% respectively. The prevalence of these
cardiac structural and functional abnormalities increased
with age, and for left atrial enlargement also with alcohol
consumption and plasma glucose, particularly in men,
and for left ventricular hypertrophy and diastolic dys-
function, respectively, also with systolic and diastolic
blood pressure.
Our finding is comparable with the results of a recent
Vietnamese study [17] and the Strong Heart Study in
American Indians for left ventricular hypertrophy [18],
and with the results of the Olmsted County studies in
the Americans [19] and the MONICA study in Germans
[20] for left ventricular diastolic dysfunction. In 508ional cardiovascular risk factors
Left ventricular mass, g E/A ratio
β ± SE Partial R2 p β ± SE Partial R2 p
1.09 ± 0.82 0.03 0.18 -0.16 ± 0.01 0.46 <0.001
23.15 ± 2.65 0.28 <0.001 -0.03 ± 0.03 0.01 0.31
2.45 ± 1.94 0.03 0.21 1.39 ± 1.95 0.01 0.47
1.07 ± 0.13 0.07 <0.001 -0.02 ± 0.01 0.02 0.21
2.65 ± 0.61 0.01 <0.001 – – –
– – – – – –
– – – -0.07 ± 0.01 0.03 <0.001
– – – -0.03 ± 0.01 0.01 0.003
in the model, and considered systolic and diastolic blood pressure, current
-to-HDL cholesterol ratio as potential confounders. P value for variables to
ror; HDL, high density lipoprotein.
Figure 1 Prevalence of left ventricular structural and functional abnormalities by age. On the left panel, left ventricular concentric
remodeling and hypertrophy were presented as filled circles with solid line, and open circles with dashed line, respectively. On the right panel,
mild and moderate-to-severe left ventricular diastolic dysfunction was presented as filled circles with solid line, and open circles with dashed line,
respectively. The number of subjects for each subgroup is given at bottom, and P for trend for each line at the right side.
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the prevalence of left ventricular hypertrophy was 8.5%
[17]. In 2400 participants of the Strong Heart Study, the
overall prevalence of left ventricular hypertrophy was
6.8% [18]. In 2042 American residents of Olmsted
County, the prevalence of mild, moderate and severe left
ventricular diastolic dysfunction was 20.8%, 6.6% and
0.7%, respectively, and significantly increased with age
[19]. In 1274 Germans in the MONICA study, the
prevalence of mild and moderate-to-severe left ventricu-
lar diastolic dysfunction was 11.1% and 3.1%, respect-
ively [20].
There is clear and solid evidence that left ventricular
hypertrophy was significantly associated with increased
systolic blood pressure. We found a significant andTable 3 Cardiac structural and functional abnormalities in rel
Left atrial enlargement * Lef
Odds ratio 95% CI p Od
Age, (+10 years) 2.67 1.45-4.93 0.002
Gender, (1 =man, 0 =woman) 0.31 0.05-1.94 0.21
Body height, (+10 cm) 1.09 0.37-3.20 0.88
Body weight, kg 1.10 1.03-1.18 0.003
Current drinking, (1 = yes, 0 = no) 3.16 0.88-11.33 0.08
Plasma glucose, mmol/L 1.29 1.06-1.55 0.009
Systolic blood pressure, (+10 mmHg) – – –
Diastolic blood pressure, (+10 mmHg) – – –
* Multinomial logistic regression was applied for left atrial enlargement and left ven
ventricular diastolic dysfunction with 0 = normal, 1 =mild diastolic dysfunction, and
we forced age, gender, body weight and body height in the model, and considered
antihypertensive drugs, plasma glucose, and total-to-HDL cholesterol ratio as poten
<0.10. CI, confidential interval.linear association between left ventricular diastolic dys-
function and diastolic blood pressure, with a slightly
steeper slope in men than in women. This association
could be explained by many possibilities. Peripheral re-
sistance is a major determinant of diastolic blood pres-
sure. When vascular remodeling in arterioles is
developed, peripheral resistance increases and coronary
flow reserve decreases, which in the long run may cause
myocardial ischemia, fibrosis, and diastolic dysfunction,
before systolic dysfunction develops. Thus, it is possible
that arterial remodeling is the common cause of diastolic
dysfunction and high diastolic blood pressure. One re-
cent study might lend indirect support for this explan-
ation [21]. In 233 subjects, diastolic dysfunction was
significantly associated with increased augmentationation to conventional cardiovascular risk factors
t ventricular hypertrophy * Left ventricular diastolic dysfunction *
ds ratio 95% CI p Odds ratio 95% CI p
1.49 1.11-2.01 0.009 3.08 2.40-3.95 <0.001
0.78 0.36-2.17 0.78 0.87 0.44-1.74 0.70
0.72 0.36-1.44 0.35 1.04 0.64-1.69 0.88
1.02 0.98-1.07 0.31 1.06 1.02-1.09 <0.001
– – – – – –
– – – – – –
1.21 1.02-1.44 0.03 – – –
– – – 1.29 1.03-1.62 0.02
tricular hypertrophy; and multinomial ordinal logistic regression for left
2 =moderate or severe diastolic dysfunction. In stepwise logistic regression,
systolic and diastolic blood pressure, current smoking and drinking, the use of
tial confounders. P value for variables to enter or stay in the model was set at
Figure 2 Prevalence of left atrial enlargement in relation to alcohol consumption and plasma glucose in men. Subjects were classified by
tertiles of daily alcohol consumption (on the left panel), with non-drinker, and mild, moderate and heavy drinking defined as daily alcohol
consumption = 0 g/d, <18 g/d, 18 to 36 g/d, and > 36 g/d, respectively, and classified by quartiles of plasma glucose (on the right panel). The
number of subjects and the range of values for each subgroup are given at bottom, and P for trend for each line at the right side.
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arterial stiffening. Of course, the cross-sectional design
of our study does not allow any causal inference.
Our finding regarding the association between left
atrial enlargement and alcohol consumption is in line
with the results of two previous studies [22,23]. In 1354
subjects of the HyperGEN study [22], it was reported
that left atrial size was positively and significantly asso-
ciated with alcohol consumption. Similarly, in aFigure 3 Prevalence of left ventricular hypertrophy and diastolic dysf
number of subjects for each subgroup is given at bottom, and P for trendrelatively smaller study (n = 48), left atrial size signifi-
cantly decreased in chronic alcoholics after a 12-day ab-
stinence [23]. Further studies, especially in a prospective
setting, are apparently warranted.
It is unexpected to find a significant association of left
atrial volume and enlargement with plasma glucose in
the present study. In literature, Milutinović S et al. have
reported that hypertensive patients with diabetes, com-
pared to those without, had significantly higher left atrialunction in relation to systolic and diastolic blood pressure. The
for each line at the right side.
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largement was significantly related to plasma glucose in
a nonlinear mode. Patients in the top quartile of plasma
glucose had high prevalence of left atrial enlargement
(7.2%), which contributed mostly to the observed signifi-
cant association. Furthermore, in a subgroup analysis in
patients without diabetes (n = 813), the associations of
left atrial volume index and enlargement with plasma
glucose were not statistically significant (P ≥ 0.07).
One of the major limitations in the present study is its
small sample size, especially in women. In addition, since
the present study was conducted in a relatively young
and healthy Chinese population, we applied a “low” cri-
terion to define left ventricular hypertrophy, which was
also recommended by ASE. If we applied the criterion of
LVMI >125 g/m2 (men) or >110 g/m2 (women) in the
present study, our major finding remained unaltered.
Specifically, the prevalence of left ventricular hyper-
trophy would be 1.7% (n = 14), and its influential factors
would include only systolic blood pressure (OR= 1.04
[95%CI: 1.01-1.06], P = 0.005). Secondly, diastolic dys-
function was solely evaluated by Pulse-wave Doppler Im-
aging, but not Tissue Doppler Imaging in the present
study. This technological limitation might, to some ex-
tent, influence the accuracy in the classification of dia-
stolic dysfunction. However, this conventional diagnostic
technique has been used in most of pervious population
studies, and is more applicable in the screening for
asymptomatic disease. Lastly, since the present popula-
tion was recruited in a factory located in southeast
China, our finding probably cannot be extrapolated to
the entire Chinese population.
Conclusions
In conclusion, even in a middle-aged and relatively
healthy Chinese population, cardiac structural and func-
tional abnormalities, mostly asymptomatic, were preva-
lent, and had higher prevalence with age advancing and
in the presence of several known cardiovascular risk fac-
tors, such as heavy drinking of alcohol, hyperglycemia,
and high blood pressure. The clinical implications of our
finding is that echocardiography probably should be per-
formed for screening subclinical cardiac structural and
functional abnormalities, especially in the elderly or in
the presence of common cardiovascular risk factors.
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